(Q33556267)

28 July 2017

title

Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine (English)

1 reference

28 July 2017

M Farr

1

1 reference

28 July 2017

D P Symmons

series ordinal

2

1 reference

28 July 2017

P A Bacon

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

44

1 reference

28 July 2017

issue

11

1 reference

28 July 2017

page(s)

798-800

1 reference

Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Sulphasalazine: a 'new' antirheumatic drug

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

The influence of drugs and disease activity on biochemical and haematological data in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001781

Sulphasalazine in rheumatoid arthritis

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2865931

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A biochemical assessment of sulphasalazine in rheumatoid arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2865931

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.44.11.798

1 reference

28 July 2017

1 reference

28 July 2017

1 reference